Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01153282
First received: June 28, 2010
Last updated: January 25, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)